In standard syringes, this dead space is approximately 0.03 to 0.07 ml (3 to 7 units)
No transdermal GLP-1 patch is approved by the Food and Drug Administration for weight loss, and that matters, because approval is what verifies a product actually contains what it claims, at the dose it claims, and does what it says
Peptides are tools
Human data on BPC-157 remains limited, and there have only been a handful of small, uncontrolled studies, none of them randomized
These regulatory changes will make Australia a more desirable destination for regulatory submissions, have a positive influence on the international standing of the Australian Therapeutic Goods Administration (TGA), and ultimately result in improved medicine registration processes and public health benefits for Australians
If you take metformin for diabetes or use proton pump inhibitors for acid reflux, your doctor might recommend monitoring your B12 status